Niamh Buckley

Dr Niamh Buckley is a Senior Lecturer in Personalised Medicine and Pharmacogenomics at the School of Pharmacy, Queen’s University Belfast. Her research integrates in vitro, in vivo, bioinformatics, and pathology approaches to identify key pathways in poor-outcome cancers like triple-negative breast cancer (TNBC) and ovarian cancer, focusing on targeted treatment options.

• Education: First Class Honours in Biochemistry from Trinity College Dublin (2002), PhD in Oncology at Queen’s University Belfast under Prof. Paul Harkin.

Her research interests emphasize Breast Cancer (particularly TNBC), BRCA1, Personalised Medicine, and Biomarker Development. Recent publications highlight advancements in Nanomedicine for cancer treatment and Vaccine Development for TNBC and ovarian cancer.

Dr Buckley has secured ~£5 million in competitive grants (with >£750,000 as PI) and published over 30 Q1 journal articles (1100+ citations). Her accolades include the All Ireland Researcher of the Year (2012), CCRCB Researcher of the Year (2012), and JD Williamson Prize (2011).

• Scientific Awards:
  • All Ireland Researcher of the Year (2012)
  • CCRCB Researcher of the Year (2012)
  • JD Williamson Prize for Research (2011)
  • Keystone Travel Award (2004)
  • Oral Presentation Award (2004)

She contributes to teaching modules in MPharm, BSc Pharmaceutical Sciences, and BSc Pharmaceutical Biotechnology, including coordination of PMY3176 and PMY3027. Dr Buckley is an active member of the Nanomedicine and Biotherapeutics Cluster and associate member of the Patrick G Johnson Centre for Cancer Research at QUB.